Grown Rogue International (GRUSF) Net Cash Flow Growth (1y) (2014 - 2026)
Grown Rogue International (GRUSF) Net Cash Flow Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 112.26% |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | -44.11% |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 209.30% |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | -236.85% |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 13,485.29% |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | -1,047.81% |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | -1,020.00% |
| 10 | Grown Rogue International | 99.97 Mn | 86.26 Mn | 3.96 Mn | -31.03% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -31.03% |
| Dec 31, 2025 | -1,292,022,235.12% |
| Mar 31, 2025 | 71.84% |
| Jan 31, 2023 | 157.39% |
| Jan 31, 2022 | -48.25% |
| Oct 31, 2021 | 19,526,036.67% |
| Jul 31, 2021 | -1,187.23% |
| Apr 30, 2021 | 326.92% |
| Jan 31, 2021 | 355.21% |
| Oct 31, 2020 | 72.66% |
| Jul 31, 2020 | -91.76% |
| Apr 30, 2020 | 679.61% |
| Jan 31, 2020 | 179.05% |
| Oct 31, 2019 | -1,023.97% |
| Jul 31, 2019 | 1,729.69% |
| Apr 30, 2019 | 75.85% |
| Jan 31, 2019 | -132.41% |
| May 31, 2018 | 10.57% |
| May 31, 2017 | -103.71% |
| Nov 30, 2016 | -1,884.19% |